Literature DB >> 7613138

The interleukin-5/receptor interaction activates Lyn and Jak2 tyrosine kinases and propagates signals via the Ras-Raf-1-MAP kinase and the Jak-STAT pathways in eosinophils.

R Alam1, K Pazdrak, S Stafford, P Forsythe.   

Abstract

We have shown that the interaction of interleukin (IL)-5 with the receptor activates Lyn tyrosine kinase within 1 min and Jak2 tyrosine kinase within 1-3 min. IL-5 also stimulates GTP binding to p21ras. The signal is subsequently propagated through the activation of Raf-1, MEK, and MAP kinases as shown by their increased autophosphorylation in vitro and phosphorylation in situ. Jak2 kinase has been shown to phosphorylate STAT nuclear proteins. The activation of STAT nuclear factors was studied by electrophoretic mobility shift assay using a gamma activation site (GAS) probe. We found that IL-5 induces two GAS-binding proteins in eosinophils, one of which is STAT1. We conclude that IL-5 induced signals are propagated through two distinct pathways: (1) Lyn-->Ras-->Raf-1-->MEK-->MAP kinase and (2) Jak2-->STAT1.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7613138     DOI: 10.1159/000236985

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  10 in total

1.  Association of SRC-related kinase Lyn with the interleukin-2 receptor and its role in maintaining constitutive phosphorylation of JAK/STAT in human T-cell leukemia virus type 1-transformed T cells.

Authors:  Maureen Shuh; Barry A Morse; Gisela Heidecker; David Derse
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

Review 2.  Interleukin-5 Antagonists Usher in a New Generation of Asthma Therapy.

Authors:  Matthew P Giannetti; Juan C Cardet
Journal:  Curr Allergy Asthma Rep       Date:  2016-11       Impact factor: 4.806

3.  Functional dissection of the cytoplasmic subregions of the interleukin-5 receptor alpha chain in growth and immunoglobulin G1 switch recombination of B cells.

Authors:  B G Moon; T Yoshida; M Shiiba; K Nakao; M Katsuki; S Takaki; K Takatsu
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

4.  IL-5 induces proliferation and activation of microglia via an unknown receptor.

Authors:  S M Liva; J de Vellis
Journal:  Neurochem Res       Date:  2001-06       Impact factor: 3.996

5.  Chemoattractant-induced signaling via the Ras-ERK and PI3K-Akt networks, along with leukotriene C4 release, is dependent on the tyrosine kinase Lyn in IL-5- and IL-3-primed human blood eosinophils.

Authors:  Yiming Zhu; Paul J Bertics
Journal:  J Immunol       Date:  2010-11-24       Impact factor: 5.422

6.  Structural basis of interleukin-5 dimer recognition by its α receptor.

Authors:  Seisuke Kusano; Mutsuko Kukimoto-Niino; Nobumasa Hino; Noboru Ohsawa; Masashi Ikutani; Satoshi Takaki; Kensaku Sakamoto; Miki Hara-Yokoyama; Mikako Shirouzu; Kiyoshi Takatsu; Shigeyuki Yokoyama
Journal:  Protein Sci       Date:  2012-04-23       Impact factor: 6.725

7.  An association study of polymorphisms in JAK3 gene with lung cancer in the Korean population.

Authors:  Wonbeak Yoo; Hae-Yun Jung; Seungjoon Lim; Jae Sook Sung; Kyong Hwa Park; Jeong Seon Ryu; Sang Won Shin; Jun Suk Kim; Jae Hong Seo; Yeul Hong Kim
Journal:  Cancer Res Treat       Date:  2011-06-30       Impact factor: 4.679

8.  Expression of IL-5 receptor alpha by murine and human lung neutrophils.

Authors:  Stacey A Gorski; Monica G Lawrence; Amy Hinkelman; MarthaJoy M Spano; John W Steinke; Larry Borish; W Gerald Teague; Thomas J Braciale
Journal:  PLoS One       Date:  2019-08-15       Impact factor: 3.240

Review 9.  Signaling Pathways That Regulate Normal and Aberrant Red Blood Cell Development.

Authors:  Mark C Wilkes; Aya Shibuya; Kathleen M Sakamoto
Journal:  Genes (Basel)       Date:  2021-10-19       Impact factor: 4.141

10.  The proliferative effects of asbestos-exposed peripheral blood mononuclear cells on mesothelial cells.

Authors:  Yuho Maki; Yasumitsu Nishimura; Shinichi Toyooka; Junichi Soh; Kazunori Tsukuda; Kazuhiko Shien; Masashi Furukawa; Takayuki Muraoka; Tsuyoshi Ueno; Norimitsu Tanaka; Hiromasa Yamamoto; Hiroaki Asano; Megumi Maeda; Naoko Kumagai-Takei; Suni Lee; Hidenori Matsuzaki; Takemi Otsuki; Shinichiro Miyoshi
Journal:  Oncol Lett       Date:  2016-04-05       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.